Literature DB >> 19029493

The natural history of invasive breast cancers detected by screening mammography.

Per-Henrik Zahl1, Jan Maehlen, H Gilbert Welch.   

Abstract

BACKGROUND: The introduction of screening mammography has been associated with sustained increases in breast cancer incidence. The natural history of these screen-detected cancers is not well understood.
METHODS: We compared cumulative breast cancer incidence in age-matched cohorts of women residing in 4 Norwegian counties before and after the initiation of biennial mammography. The screened group included all women who were invited for all 3 rounds of screening during the period 1996 through 2001 (age range in 1996, 50-64 years). The control group included all women who would have been invited for screening had there been a screening program during the period 1992 through 1997 (age range in 1992, 50-64 years). All women in the control group were invited to undergo a 1-time prevalence screen at the end of their observation period. Screening attendance was similar in both groups (screened, 78.3%, and controls, 79.5%). Counts of incident invasive breast cancers were obtained from the Norwegian Cancer Registry (in situ cancers were excluded).
RESULTS: As expected, before the age-matched controls were invited to be screened at the end of their observation period, the cumulative incidence of invasive breast cancer was significantly higher in the screened group than in the controls (4-year cumulative incidence: 1268 vs 810 per 100 000 population; relative rate, 1.57; 95% confidence interval, 1.44-1.70). Even after prevalence screening in controls, however, the cumulative incidence of invasive breast cancer remained 22% higher in the screened group (6-year cumulative incidence: 1909 vs 1564 per 100 000 population; relative rate, 1.22; 95% confidence interval, 1.16-1.30). Higher incidence was observed in screened women at each year of age.
CONCLUSIONS: Because the cumulative incidence among controls never reached that of the screened group, it appears that some breast cancers detected by repeated mammographic screening would not persist to be detectable by a single mammogram at the end of 6 years. This raises the possibility that the natural course of some screen-detected invasive breast cancers is to spontaneously regress.

Entities:  

Mesh:

Year:  2008        PMID: 19029493     DOI: 10.1001/archinte.168.21.2311

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  63 in total

1.  An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts.

Authors:  Bernard Junod; Per-Henrik Zahl; Robert M Kaplan; Jørn Olsen; Sander Greenland
Journal:  BMC Cancer       Date:  2011-09-21       Impact factor: 4.430

2.  [Clinical economics: a concept to optimize healthcare services].

Authors:  F Porzsolt; K Bauer; D Henne-Bruns
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

3.  The Epidemiology and Aetiology of Female Breast Cancer.

Authors:  Andreas Stang; Rita K Schmutzler
Journal:  Breast Care (Basel)       Date:  2009-04-24       Impact factor: 2.860

Review 4.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

Review 5.  Purinergic mechanisms in breast cancer support intravasation, extravasation and angiogenesis.

Authors:  Iain L O Buxton; Nucharee Yokdang; Robert M Matz
Journal:  Cancer Lett       Date:  2010-05-28       Impact factor: 8.679

Review 6.  The breast screening programme and misinforming the public.

Authors:  Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  J R Soc Med       Date:  2011-09       Impact factor: 5.344

7.  A limited Review of Over Diagnosis Methods and Long Term Effects in Breast Cancer Screening.

Authors:  Dongfeng Wu; Adriana Pérez
Journal:  Oncol Rev       Date:  2011-09-01

8.  Overdiagnosis in organised mammography screening in Denmark. A comparative study.

Authors:  Karsten J Jørgensen; Per-Henrik Zahl; Peter C Gøtzsche
Journal:  BMC Womens Health       Date:  2009-12-22       Impact factor: 2.809

9.  The preclinical natural history of serous ovarian cancer: defining the target for early detection.

Authors:  Patrick O Brown; Chana Palmer
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

10.  Magnetic resonance imaging of the natural history of in situ mammary neoplasia in transgenic mice: a pilot study.

Authors:  Sanaz A Jansen; Suzanne D Conzen; Xiaobing Fan; Erica J Markiewicz; Gillian M Newstead; Gregory S Karczmar
Journal:  Breast Cancer Res       Date:  2009       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.